While the exact treatment combination that was used for this patient has not been studied in a randomized controlled trial for breast cancer, we do note that chemotherapy is routinely used in combination with PD1 blockade or in combination with anti-HER2 therapy separately. The gene discussed is ERBB2; the disease is breast cancer.